Surgical Innovation

A clinical breakdown of the six levels of surgical robot autonomy, from robot assistance to full autonomy, and where today's cleared systems actually stand.

Ottava and da Vinci 5 compared on architecture, force feedback, FDA clearance, and OR footprint. A surgeon's technical breakdown for 2026.

Medtronic's Touch Surgery Aide brings real-time AI into live robotic procedures, starting with a safety application solving a risk surgeons rarely talk about.

NVIDIA is using simulation, synthetic data and reinforcement learning to train robotic systems for hospital automation and future autonomous surgery.

UC San Diego researchers used teleoperated humanoid robots to perform laparoscopic surgery in pigs, testing whether general-purpose robots can operate in the OR.

Every operation leaves behind a record. Video captures what happened. Vital signs show how the patient responded. Robotic systems record instrument movements. Anesthesia systems capture physiological changes. Yet most of this information remains disconnected once the operation ends. Surgical data science is bringing those signals together. From Surgical Video to Surgical Intelligence AI can now analyze recorded procedures to recognize instruments, anatomical structures, and s

Pancreatic cancer is usually diagnosed too late for curative surgery. More than 85% of patients present with advanced disease, when resection is no longer possible. Researchers at Mayo Clinic have developed an AI model that detects imaging changes months before pancreatic cancer becomes visible on routine CT scans. Looking beyond the tumor The model, called REDMOD, analyzes radiomic features throughout the pancreas instead of searching for a visible mass. In a validation stud

Administrative work remains one of the largest sources of physician workload. Discharge summaries are a prime example, requiring clinicians to accurately document a hospital stay while ensuring continuity of care after discharge. A team at Stanford Medicine evaluated whether an AI assistant could help. AI drafts, physicians approve Researchers developed MedAgentBrief, an AI agent that generated discharge summaries from the electronic health record. During a 10-week pilot in a

The biggest problem in battlefield trauma is often not the injury itself. It is the time between injury and surgery. SS Innovations is developing a system designed for that gap: a surgical robot delivered directly to the trauma zone. How Vimana Aero works The SSi Vimana Aero is a heavy-lift drone carrying two robotic arms. After landing near a casualty, it connects the system to a trauma surgeon remotely operating through the SSi Mantra command center. The robotic arms have s

Credit: Intuitive Surgical Cardiac surgery has always been the hardest challenge for surgical robotics. A valve repair depends on something robots still struggle to reproduce: touch. Surgeons feel tissue tension, resistance, and the difference between a secure stitch and a dangerous one. That is why cardiac surgery lagged behind urology and gynecology. In January, the FDA cleared Intuitive Surgical’s da Vinci 5 for nine cardiac procedures, including mitral valve repair, tricu

Artificial intelligence is becoming part of everyday clinical practice, but evidence on how physicians should use it safely is still catching up. That tension is highlighted in a recent article by The Atlantic, which brings together several new studies on AI-assisted clinical reasoning and the risks of premature adoption. Strong performance does not guarantee safe use In a study published in Science, researchers from Harvard and Stanford found that ChatGPT outperformed hundre

Look at every surgical robot the FDA has cleared. A pattern jumps out. Almost all of them sit at the lowest rung of autonomy. They do exactly what the surgeon tells them, moment to moment. A small number can execute a preplanned task on their own. Fewer still can adjust that plan in real time. None, so far, can plan and carry out a full sequence of surgical steps without a human in the loop. That gap between what robots can execute and what surgeons must still decide isn't a

Artificial intelligence is starting to change breast cancer care before treatment even begins. Researchers at UCSF and UC Berkeley used an AI model called Mirai to identify women at high risk immediately after screening mammography and move them into expedited diagnostic evaluation. The workflow reduced diagnostic assessment from weeks to about one hour. Among women diagnosed with breast cancer, the median time to biopsy fell from more than two months to fewer than ten days.

For twenty years, robotic soft-tissue surgery had one name. On July 22, 2026, that changed. J&J's Ottava received FDA de novo authorization. Not a niche entrant. A real alternative. A fundamental design break Da Vinci 5 is an evolution. Ottava is a reset. Intuitive still wheels in a cart and tower, positioned and calibrated before each case. Ottava builds four arms into the table itself, hidden until needed. No cart. No external footprint. J&J claims a 30 to 50 percent smalle

Researchers at the University of Bern have developed an artificial intelligence model that predicts a patient's risk of postoperative infection immediately after surgery, using physiologic data collected during the operation rather than relying only on preoperative risk factors. Why it matters Postoperative infections remain one of the leading causes of surgical complications, contributing to longer hospital stays, higher healthcare costs, and increased mortality. Traditional

Choosing a surgical robot is no longer a one-company decision. For years, Intuitive's da Vinci platform dominated robotic soft tissue surgery. Today, Medtronic's Hugo and Johnson & Johnson's Ottava offer hospitals alternative approaches, each built around different priorities. All three platforms allow surgeons to perform minimally invasive procedures with robotic assistance. None performs surgery autonomously. The differences lie in design, workflow, clinical experience, and

For years, one company defined robotic surgery. That changed this week. From a landmark FDA authorization to advances in AI-powered surgical assistance, these are the five developments that mattered most in surgical innovation this week. 1. Johnson & Johnson Enters the U.S. Robotic Surgery Market Johnson & Johnson Johnson & Johnson's OTTAVA received FDA authorization for soft tissue surgery, marking the company's official entry into the U.S. robotic surgery market. The table-

Surgery has always been learned through experience. Watch. Assist. Operate. Repeat. That model still works. But surgery is changing. Artificial intelligence, robotic platforms, simulation, and digital operating rooms are reshaping how surgeons develop technical skills and clinical judgment. The future of surgical education is not replacing traditional training. It is expanding it. Simulation comes first Simulation allows trainees to practice before operating on patients. Mode

A surgeon's eyes are good. They are not infinite. An instrument tip can drift past the edge of the camera's view and come back before anyone notices. A tumor margin can look clean under white light and still hide malignant cells a millimeter away. A case can shift phases faster than anyone tracks it in real time. Computer vision does not replace the surgeon's eyes. It adds a second set. One that never blinks and never tires near hour six. Watching what the surgeon can't Medtr

For almost twenty years, robotic surgery asked surgeons to give something up. Tremor-free precision. 3D vision. Wristed dexterity. All of it came at the cost of touch. A surgeon could see tissue tense under an instrument tip. They couldn't feel it. That trade is reversing. The first system that let surgeons feel again Asensus Surgical's Senhance system won FDA clearance in 2017. It offered something no robotic platform had before: haptic feedback that lets a surgeon feel tiss